Tackle cancers with substantial unmet need
Increase our research spend in lung, pancreatic, oesophageal cancers and brain tumours
We are increasing our investment in each of the cancers of unmet need two- to threefold over five years to strengthen long-term research capacity. We are:
Increasing focus on these cancers in our Institutes and Centres
Prioritising them in our existing funding streams, and working with the research community to grow their share of competitive funding
Prioritising them in our strategic initiatives such as the Stratified Medicine programme
Making targeted investments to build leadership and facilitate training and networking
Working with other cancer-specific charities, particularly in brain and pancreatic cancer.
Support research into rare cancers
There is currently a high unmet medical need and lack of research investment in rare cancers, which make up around a fifth of all cancer diagnoses in Europe. We continue to support a range of clinical research into rare cancers, including through our participation in the International Rare Cancers Initiative (IRCI) partnership.
Increase our support for childhood and youth cancers
Although rare, cancer is still the most common cause of death in children. We are the major funder of childhood cancer research in the UK, and with limited industry investment in this area, we have an important role to play. We're increasing investment through our committees and working with the research community to address key issues currently inhibiting progress. We support research into cancers where survival is low, and research to address long-term side effects of treatment and quality of life issues for survivors.
Opportunities for your research
We're prioritising cancers of unmet need across our funding streams, at all stages of career development and the research pipeline and patient pathway. Our Research Funding Managers are available to discuss and help you develop your ideas.